HepatologyVolume 74, Issue 4 p. 2241-2250 Concise Review Emerging Role of Genomic Analysis in Clinical Evaluation of Lean Individuals With NAFLD Sílvia Vilarinho, Corresponding Author roloomba@ucsd.edu silvia.vilarinho@yale.edu Department of Internal Medicine, Section of Digestive Diseases and of Pathology, Yale School of Medicine, New Haven, CT These authors contributed equally to this work. ADDRESS CORRESPONDENCE AND REPRINT REQUESTS TO: Rohit Loomba, M.D., M.H.Sc. Division of Gastroenterology and Hepatology, University of California at San Diego 1W202, ACTRI Building La Jolla, CA, 92093-0887 E-mail: roloomba@ucsd.edu Tel.: 858-246-2201 or Sílvia Vilarinho, M.D., Ph.D. Department of Internal Medicine, Section of Digestive Diseases and of Pathology, Yale School of Medicine New Haven, CT 06520 E-mail: silvia.vilarinho@yale.edu Tel.: 858-246-2201Search for more papers by this authorVeeral Ajmera, orcid.org/0000-0001-5626-0942 NAFLD Research Center, Division of Gastroenterology, University of California at San Diego, La Jolla, CA These authors contributed equally to this work.Search for more papers by this authorMelanie Zheng, Department of Internal Medicine, Section of Digestive Diseases and of Pathology, Yale School of Medicine, New Haven, CTSearch for more papers by this authorRohit Loomba, Corresponding Author roloomba@ucsd.edu orcid.org/0000-0002-4845-9991 NAFLD Research Center, Division of Gastroenterology, University of California at San Diego, La Jolla, CA ADDRESS CORRESPONDENCE AND REPRINT REQUESTS TO: Rohit Loomba, M.D., M.H.Sc. Division of Gastroenterology and Hepatology, University of California at San Diego 1W202, ACTRI Building La Jolla, CA, 92093-0887 E-mail: roloomba@ucsd.edu Tel.: 858-246-2201 or Sílvia Vilarinho, M.D., Ph.D. Department of Internal Medicine, Section of Digestive Diseases and of Pathology, Yale School of Medicine New Haven, CT 06520 E-mail: silvia.vilarinho@yale.edu Tel.: 858-246-2201Search for more papers by this author Sílvia Vilarinho, Corresponding Author roloomba@ucsd.edu silvia.vilarinho@yale.edu Department of Internal Medicine, Section of Digestive Diseases and of Pathology, Yale School of Medicine, New Haven, CT These authors contributed equally to this work. ADDRESS CORRESPONDENCE AND REPRINT REQUESTS TO: Rohit Loomba, M.D., M.H.Sc. Division of Gastroenterology and Hepatology, University of California at San Diego 1W202, ACTRI Building La Jolla, CA, 92093-0887 E-mail: roloomba@ucsd.edu Tel.: 858-246-2201 or Sílvia Vilarinho, M.D., Ph.D. Department of Internal Medicine, Section of Digestive Diseases and of Pathology, Yale School of Medicine New Haven, CT 06520 E-mail: silvia.vilarinho@yale.edu Tel.: 858-246-2201Search for more papers by this authorVeeral Ajmera, orcid.org/0000-0001-5626-0942 NAFLD Research Center, Division of Gastroenterology, University of California at San Diego, La Jolla, CA These authors contributed equally to this work.Search for more papers by this authorMelanie Zheng, Department of Internal Medicine, Section of Digestive Diseases and of Pathology, Yale School of Medicine, New Haven, CTSearch for more papers by this authorRohit Loomba, Corresponding Author roloomba@ucsd.edu orcid.org/0000-0002-4845-9991 NAFLD Research Center, Division of Gastroenterology, University of California at San Diego, La Jolla, CA ADDRESS CORRESPONDENCE AND REPRINT REQUESTS TO: Rohit Loomba, M.D., M.H.Sc. Division of Gastroenterology and Hepatology, University of California at San Diego 1W202, ACTRI Building La Jolla, CA, 92093-0887 E-mail: roloomba@ucsd.edu Tel.: 858-246-2201 or Sílvia Vilarinho, M.D., Ph.D. Department of Internal Medicine, Section of Digestive Diseases and of Pathology, Yale School of Medicine New Haven, CT 06520 E-mail: silvia.vilarinho@yale.edu Tel.: 858-246-2201Search for more papers by this author First published: 07 July 2021 https://doi.org/10.1002/hep.32047 Supported by National Institute of Environmental Health Sciences (5P42ES010337), National Center for Advancing Translational Sciences (5UL1TR001442), Department of Defense Peer Reviewed Cancer Research Program (W81XWH-18-2-0026), National Institute of Diabetes and Digestive and Kidney Diseases (U01DK061734, R01DK106419, R01DK121378, R01DK124318, P30DK120515, K23DK119460, and K08 DK113109), National Heart, Lung, and Blood Institute (P01HL147835), and National Institute on Alcohol Abuse and Alcoholism (U01AA029019), and Doris Duke Charitable Foundation (2019081). Potential conflict of interest: Dr. Loomba consults and received grants from AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Galmed, Gilead, Intercept, Janssen, Madrigal, NGM, and Pfizer. He consults for Alnylam/Regeneron, Amgen, Arrowhead, CohBar, Glympse, Ionis, Inipharm, Metacrine, Novartis, Novo Nordisk, Sagimet, 89Bio, and Viking. He received grants from Allergan, Boehringer Ingelheim, Galectin, Genfit, Inventiva, Merck, and Siemens. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinked InRedditWechat Volume74, Issue4October 2021Pages 2241-2250 RelatedInformation
Read full abstract